NASDAQ:HSAQ Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free HSAQ Stock Alerts $4.39 -0.05 (-1.13%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$4.36▼$4.6050-Day Range$4.39▼$7.1252-Week Range$9.41▼$13.80Volume24,286 shsAverage Volume205,918 shsMarket Capitalization$49.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Get Health Sciences Acquisitions Co. 2 alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.Read More HSAQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSAQ Stock News HeadlinesApril 26, 2024 | bizjournals.comTriangle exec forms PE-backed companyApril 24, 2024 | chron.comCommunity Health Systems: Q1 Earnings SnapshotApril 27, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 23, 2024 | seekingalpha.comBaron Health Care Fund Q1 2024 Shareholder LetterFebruary 16, 2024 | msn.comXoma to acquire Kinnate Biopharma for $2.3352 - $2.5879 per shareNovember 7, 2023 | msn.comPrecision BioSciences GAAP EPS of -$0.07, revenue of $13.12MAugust 16, 2023 | axios.comJPMorgan, Oppenheimer advising Cano HealthAugust 7, 2023 | latimes.comNIH ices research on health communication and misinformation. Is it self-censorship?April 27, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 13, 2023 | bizjournals.comHealthcare and life sciences industry leaders optimistic despite historic upheavals and great uncertaintyApril 11, 2023 | markets.businessinsider.comDISCOVERY LIFE SCIENCES ACQUIRES REACHBIO RESEARCH LABSJanuary 27, 2023 | finance.yahoo.comOrchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business ModelJanuary 24, 2023 | usnews.comWhat You Need to Know About Becoming a Health Science MajorJanuary 6, 2023 | finance.yahoo.comHealth Sciences Acquisitions Corporation 2 (HSAQ)September 20, 2022 | finance.yahoo.comOrchestra BioMed™ Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT™ at TCT 2022September 16, 2022 | msn.comFrom sports tech to health care, Boston is exporting innovationSeptember 16, 2022 | forbes.comAddressing The Disconnect Between American Healthcare And Modern SocietySeptember 13, 2022 | msn.comFree preventive care under the ACA is under threat again – a ruling exempting PrEP from insurance coverage may extend nationwide and to other health servicesSeptember 13, 2022 | msn.comAnPac Bio-Medical Sciences faces possible stock exchange delisting due to stock priceSeptember 13, 2022 | finance.yahoo.comNuminus provides update on acquisition integration and announces new client financing optionsSeptember 13, 2022 | finance.yahoo.comNew Research from the Clarify Health Institute Highlights the Severity of Pediatric Mental Health Conditions in the United StatesSeptember 12, 2022 | news.yahoo.comChildren’s mental health issues have increased, insurance claims suggestSeptember 12, 2022 | cnbc.comThis little-known senior health care stock can surge more than 60%, Goldman Sachs saysSeptember 9, 2022 | msn.comI wouldn’t spend money on microbiome skincare products. The science isn’t there | OpinionSeptember 9, 2022 | markets.businessinsider.com$11.3 million NIH Superfund award to address environmental health issues caused by VOCsSeptember 9, 2022 | wsj.comAffordable Care Act Health-Plan Premiums Set to RiseSeptember 7, 2022 | apnews.comBiophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory FailureSee More Headlines Receive HSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:HSAQ CUSIPN/A CIK1814114 WebN/A PhoneN/AFaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-380,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-2.38% Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.61 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.62) per share Price / Book-7.08Miscellaneous Outstanding Shares11,212,000Free Float8,757,000Market Cap$49.22 million OptionableNot Optionable Beta0.09 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Roderick Tze Ian Wong M.D. (Age 46)Pres, CEO & Chairman Dr. Naveen Yalamanchi M.D. (Age 46)Exec. VP, CFO & Director Ms. Alice Lee J.D. (Age 52)VP of Operations, Sec. & Treasurer Ms. Stephanie A. Sirota (Age 47)VP of Corp. Strategy & Corp. Communications Key CompetitorsCytosorbentsNASDAQ:CTSODaxorNASDAQ:DXRInspireMDNYSE:NSPRApyx MedicalNASDAQ:APYXIceCure MedicalNASDAQ:ICCMView All Competitors HSAQ Stock Analysis - Frequently Asked Questions How have HSAQ shares performed in 2024? Health Sciences Acquisitions Co. 2's stock was trading at $9.13 at the start of the year. Since then, HSAQ stock has decreased by 51.9% and is now trading at $4.39. View the best growth stocks for 2024 here. What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Sciences Acquisitions Co. 2 investors own include Harbor Custom Development (HCDI), Gores Holdings V (GRSVU), FS Development (FSDC), Freeline Therapeutics (FRLN), Duck Creek Technologies (DCT), CureVac (CVAC), Checkmate Pharmaceuticals (CMPI), Burlington Stores (BURL), BigCommerce (BIGC) and KE (BEKE). When did Health Sciences Acquisitions Co. 2 IPO? Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering (IPO) on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays acted as the underwriters for the IPO. How do I buy shares of Health Sciences Acquisitions Co. 2? Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSAQ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
